1don MSN
Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...
A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...
The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...
Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility across genetic and non-genetic risk groups.
Researchers developed MechanoAge, an AI-driven platform that predicts breast cancer risk by analyzing how cells deform under ...
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at ...
Patient recounts IL‑2 therapy chills, rigors, ICU seizure scare, and recovery—what treatment feels like and why monitoring ...
The results, published May 5 in Nature Genetics, offer a new way to understand the molecular roots of cancer — an especially ...
Morning Overview on MSN
Study links extra chromosome sets to tumor spread and cell mobility
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results